Table 2 Previous reports of patients with non-neuroendocrine tumor + typical or atypical carcinoid in the lung
| Â | Histology | Age/Sex | Smoking | Location | Ki-67 LI in TC/AC | Ki-67 LI in Ad/Sq | Tumor size | Metastasis/Histology | Reccurence | Survival/death | Refference |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | TC + Ad | 60/M | + | L/Peripheral | NA | NA | 20 mm | Lymph node/Ad | – | Survival | Sen, et al. 1998 [2] |
2 | TC + Sq | 71/F | + | L/Central | < 1% | < 50% | 50 mm | Lymph node/NA | NA | NA | Owens, et al. 2011 [3] |
3 | TC + Ad | 67/F | + | R/Peripheral | NA | NA | 18 mm | – | – | Survival | Nagamatsu, et al. 2011 [7] |
4 | TC + Ad | 74/F | + | L/Peripheral | NA | NA | 13 mm | – | NA | NA | Abbi, et al. 2014 [4] |
5 | AC + Sq | 71/M | + | R/Peripheral | NA | NA | 70 mm | – | Metastases to brain and adrenal | Died of pneumonia, 21 months after the surgery | Okazaki, et al. 2015 [5] |
6 | AC + Ad | 66/M | + | R/Peripheral | NA | NA | 17 mm | – | – | Survival | Olofson, et al. 2018 [6] |
7 | AC + Ad | NA | NA | Peripheral | NA | NA | NA | NA | – | Survival | Ruffini, et al. 2002 [8] |
8 | TC + Sq | NA | NA | Peripheral | NA | NA | NA | NA | – | Survival | Ruffini, et al. 2002 [8] |
9 | Carcinoid, NOS + Ad | 53/M | NA | R | NA | NA | NA | NA | NA | NA | Li, et al. 2015 [9] |
10: Case 1 | AC + Ad | 77/F | - | L/Peripheral | 16.7% | < 1% | 29 mm | – | – | Survival | Present case |
11: Case 2 | TC + Ad | 83/F | + | L/Peripheral | 2.0% | 3.2% | 25 mm | – | – | Survival | Present case |